NASDAQ:ALDX - Aldeyra Therapeutics, Inc.
$7.76
 $0.07
+0.91%
4:00PM EDT
2019-04-18
Aldeyra Therapeutics, Inc., formerly Aldexa Therapeutics, Inc., is a biotechnology company. The Company's principal activities include raising capital and research and development activities. The Company's segment is the identification and development of a treatment for diseases related to high levels of aldehydes. The Company is focused on the development of products for diseases caused by inflammation and inborn errors of metabolism that are caused by naturally occurring toxic and pro-inflammatory chemical species known as aldehydes. The Company has developed a series of aldehyde traps, molecules that are designed to sequester and allow for the degradation of aldehydes. The Company's aldehyde trap, NS2, is a product candidate that is under development for the treatment of allergic conjunctivitis and related rare allergic ocular diseases, noninfectious anterior uveitis, sjogren-larsson syndrome (SLS) and succinic semi-aldehyde dehydrogenase deficiency. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ALDX     avg for
industry  
  avg for
sector  
42 stocks weight:  5. 81   203. 85   241. 91  
42 stocks rank:  3. 14 K 1. 44 K 1. 05 K
# analyst opinions:  8. 00   14. 51   13. 97  
mean recommendation:  1. 50   2. 09   2. 01  

quick ratio:  5. 85   5. 27   1. 81  
current ratio:  11. 19   5. 62   2. 25  

target price low:  20. 00   84. 80   115. 21  
target price avg:  9. 51   111. 51   137. 51  
target price high:  12. 10   135. 81   157. 84  
1-yr high:  14. 35   114. 23   138. 78  
last close:  7. 76   87. 66   116. 69  
50-day avg:  8. 23   95. 54   123. 44  
200-day avg:  8. 92   94. 25   121. 11  
1-yr low:  6. 80   72. 78   98. 34  
volume:  258. 41 K 4. 11 M 8. 07 M
50-day avg volume:  804. 61 K 2. 76 M 5. 02 M
200-day avg volume:  489. 04 K 2. 92 M 4. 59 M

1-day return:  0. 91 % -0. 41 % 0. 07 %
this week return:  -5. 13 % -5. 74 % -4. 11 %
12-wk return:  -10. 39 % 1. 61 % -0. 05 %
52-wk return:  7. 55 % 3. 12 % 8. 78 %

enterprise value (EV):  -1. 14 M 48. 94 B 114. 64 B
market cap:  212. 59 M 43. 07 B 104. 73 B
EBITDA:  -39. 63 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  0. 03   4. 22   12. 73  
total debt:  0. 00   12. 24 B 16. 73 B
net income (common):  -38. 89 M 2. 20 B 4. 20 B

shares outstanding:  27. 40 M 571. 70 M 1. 24 B
shares:  4. 73 M 571. 81 M 1. 23 B
shares short:  1. 17 M 10. 17 M 13. 00 M
shares short prior month:  679. 36 K 9. 54 M 17. 33 M
short ratio:  0. 82   5. 41   3. 28  
short % of float:  8. 09 % 5. 45 % 2. 38 %
total cash/share:  7. 94   11. 14   9. 33  
total cash:  49. 60 M 6. 71 B 7. 15 B
free cash flow:  -41. 81 M 3. 58 B 2. 96 B
operating cash flow:  -29. 86 M 4. 15 B 4. 30 B

book value:  3. 30   12. 78   26. 92  
price/book:  2. 35   3. 06   -1. 74  
operating margins:  0. 00 % -725. 35 % -89. 04 %
EBITDA margins:  0. 00 % 10. 94 % 22. 51 %
profit margins:  0. 00 % 7. 81 % 10. 57 %
gross margins:  0. 00 % 37. 08 % 55. 70 %

1-yr max volatility:  35. 99 % --- ---
1-yr mean volatility:  0. 14 % 0. 03 % 0. 04 %

1-yr EPS:  -1. 79   2. 40   4. 10  
forward EPS:  -1. 77   3. 97   7. 13  
P/E:  -4. 33   13. 63   22. 72  
forward P/E:  -4. 38   -15. 95   13. 99  
PE/G:  1. 13   -1. 65   -1. 32  
growth:  -3. 84 % 127. 12 % 29. 61 %
earnings high:  -0. 38   1. 00   1. 66  
earnings avg:  -0. 43   0. 77   1. 53  
earnings low:  -0. 52   0. 50   1. 39  
revenue high:  -0. 00   2. 68 B 10. 78 B
revenue avg:  -0. 00   2. 59 B 10. 57 B
revenue low:  -0. 00   2. 49 B 10. 36 B
return on assets:  -35. 63 % -2. 75 % 4. 55 %
return on equity:  -61. 63 % -18. 45 % 5. 46 %

beta (1yr vs S&P500):  1. 40   1. 25   0. 93  
sharpe (1yr):  0. 48   0. 37   0. 70  

held % insiders:  1. 94 % 6. 39 % 3. 38 %
held % institutions:  73. 18 % 78. 14 % 68. 52 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : ALDX
.    + 0.992 =         0.992 :: INITIAL WEIGHT
.   + 79.087 =        80.079 :: inverse volume-to-price addition
.   + 43.153 =       123.232 :: spline projection addition
.    x 2.739 =       337.586 :: 13 weeks' performance factor
.    x 1.101 =       371.584 :: one-year gains+dividend factor
.    x 1.431 =       531.894 :: industry recommendation factor
.    x 3.016 =      1604.046 :: symbol recommendation factor
.    x 0.996 =       1598.33 :: return on assets factor
.    x 0.994 =       1588.48 :: return on equity factor
.    x 2.011 =      3194.889 :: current ratio factor
.    x 1.098 =      3508.587 :: quick ratio factor
.    x 1.544 =      5417.221 :: short ratio factor
.    x 2.024 =     10961.828 :: price-to-book factor
.    x 1.003 =     10999.453 :: EBITDA multiple vs industry factor
.    x 5.698 =     62670.318 :: EBITDA multiple factor
.      x 2.1 =    131611.591 :: P/E weight
.    x 0.971 =     127767.15 :: PE/G factor
.    x 1.376 =    175827.285 :: beta factor
.    x 0.476 =     83771.627 :: sharpe factor
.    x 2.455 =    205649.508 :: target low factor
.    x 1.158 =    238212.997 :: target mean factor
.    x 1.075 =    256019.063 :: target high factor
.     x 1.31 =    335356.272 :: industry 2-weeks return factor
.    x 0.999 =    335041.937 :: overall "drift" factor
.     x 0.64 =    214445.599 :: largest single-day jump factor
.    x 0.106 =     22764.926 :: low price factor
.      x 1.0 =     22761.231 :: factor hist industry gain for week 16
.   cubeRoot =         28.34 :: reduced to standardize
.   - 22.526 =         5.814 :: add/subtract for performance
.                      5.814 :: FINAL WEIGHT for NASDAQ:ALDX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org